Details
| Stereochemistry | ACHIRAL |
| Molecular Formula | C22H24FN3O2 |
| Molecular Weight | 381.4433 |
| Optical Activity | NONE |
| Defined Stereocenters | 0 / 0 |
| E/Z Centers | 0 |
| Charge | 0 |
SHOW SMILES / InChI
SMILES
FC1=CC=C(C=C1)C(=O)C2CCN(CCCN3C(=O)NC4=C3C=CC=C4)CC2
InChI
InChIKey=VNLMLHDKNUIWNM-UHFFFAOYSA-N
InChI=1S/C22H24FN3O2/c23-18-8-6-16(7-9-18)21(27)17-10-14-25(15-11-17)12-3-13-26-20-5-2-1-4-19(20)24-22(26)28/h1-2,4-9,17H,3,10-15H2,(H,24,28)
| Molecular Formula | C22H24FN3O2 |
| Molecular Weight | 381.4433 |
| Charge | 0 |
| Count |
|
| Stereochemistry | ACHIRAL |
| Additional Stereochemistry | No |
| Defined Stereocenters | 0 / 0 |
| E/Z Centers | 0 |
| Optical Activity | NONE |
Declenperone is an antagonist of 5-HT2 receptors, developed by Janssen Pharmaceutica. The compound is claimed to have strong neuroleptic activity, as evidenced by experimental data obtained in apomorphine-tryptamine and norepinephrine test in rats, and the apomorphine test in dogs. Declenperone was used in a veterinary as a sedative.
Originator
Approval Year
| Substance Class |
Chemical
Created
by
admin
on
Edited
Mon Mar 31 18:26:16 GMT 2025
by
admin
on
Mon Mar 31 18:26:16 GMT 2025
|
| Record UNII |
280VGV0X4H
|
| Record Status |
Validated (UNII)
|
| Record Version |
|
-
Download
| Name | Type | Language | ||
|---|---|---|---|---|
|
Official Name | English | ||
|
Preferred Name | English | ||
|
Systematic Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Code | English | ||
|
Code | English | ||
|
Common Name | English |
| Classification Tree | Code System | Code | ||
|---|---|---|---|---|
|
NCI_THESAURUS |
C28197
Created by
admin on Mon Mar 31 18:26:16 GMT 2025 , Edited by admin on Mon Mar 31 18:26:16 GMT 2025
|
| Code System | Code | Type | Description | ||
|---|---|---|---|---|---|
|
CHEMBL2104228
Created by
admin on Mon Mar 31 18:26:16 GMT 2025 , Edited by admin on Mon Mar 31 18:26:16 GMT 2025
|
PRIMARY | |||
|
100000083472
Created by
admin on Mon Mar 31 18:26:16 GMT 2025 , Edited by admin on Mon Mar 31 18:26:16 GMT 2025
|
PRIMARY | |||
|
C76938
Created by
admin on Mon Mar 31 18:26:16 GMT 2025 , Edited by admin on Mon Mar 31 18:26:16 GMT 2025
|
PRIMARY | |||
|
71744
Created by
admin on Mon Mar 31 18:26:16 GMT 2025 , Edited by admin on Mon Mar 31 18:26:16 GMT 2025
|
PRIMARY | |||
|
SUB06934MIG
Created by
admin on Mon Mar 31 18:26:16 GMT 2025 , Edited by admin on Mon Mar 31 18:26:16 GMT 2025
|
PRIMARY | |||
|
63388-37-4
Created by
admin on Mon Mar 31 18:26:16 GMT 2025 , Edited by admin on Mon Mar 31 18:26:16 GMT 2025
|
PRIMARY | |||
|
280VGV0X4H
Created by
admin on Mon Mar 31 18:26:16 GMT 2025 , Edited by admin on Mon Mar 31 18:26:16 GMT 2025
|
PRIMARY | |||
|
DTXSID20212789
Created by
admin on Mon Mar 31 18:26:16 GMT 2025 , Edited by admin on Mon Mar 31 18:26:16 GMT 2025
|
PRIMARY | |||
|
4756
Created by
admin on Mon Mar 31 18:26:16 GMT 2025 , Edited by admin on Mon Mar 31 18:26:16 GMT 2025
|
PRIMARY | |||
|
328505
Created by
admin on Mon Mar 31 18:26:16 GMT 2025 , Edited by admin on Mon Mar 31 18:26:16 GMT 2025
|
PRIMARY |
| Related Record | Type | Details | ||
|---|---|---|---|---|
|
|
ACTIVE MOIETY |